METROPOLITAN LIFE INSURANCE CO/NY - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$105,777
-99.9%
31,1110.0%0.00%0.0%
Q2 2018$116,977,000
+3.5%
31,111
+12.5%
0.00%0.0%
Q1 2018$113,072,000
+115279.6%
27,646
+31.7%
0.00%
+100.0%
Q4 2017$98,000
-76.7%
20,994
-64.5%
0.00%
-66.7%
Q3 2017$420,000
-1.4%
59,149
+0.5%
0.00%0.0%
Q2 2017$426,000
+39.2%
58,863
+18.6%
0.00%
+50.0%
Q1 2017$306,000
-18.4%
49,633
-22.5%
0.00%
-33.3%
Q4 2016$375,000
+17.6%
64,077
+6.6%
0.00%
+50.0%
Q3 2016$319,000
-35.8%
60,083
-20.0%
0.00%
-50.0%
Q2 2016$497,000
+41.6%
75,1080.0%0.00%
+33.3%
Q1 2016$351,000
-6.4%
75,108
+1.2%
0.00%0.0%
Q4 2015$375,000
+43.7%
74,2340.0%0.00%
+50.0%
Q3 2015$261,000
-65.2%
74,234
-1.1%
0.00%
-60.0%
Q2 2015$749,000
-25.4%
75,052
-4.9%
0.01%
-28.6%
Q1 2015$1,004,000
-1.9%
78,887
+9.1%
0.01%0.0%
Q4 2014$1,023,000
+2.9%
72,2990.0%0.01%0.0%
Q3 2014$994,000
-10.6%
72,2990.0%0.01%
-12.5%
Q2 2014$1,112,000
-9.7%
72,2990.0%0.01%
-11.1%
Q1 2014$1,232,000
+44.8%
72,299
+10.1%
0.01%
+50.0%
Q4 2013$851,000
+28.4%
65,6870.0%0.01%
+20.0%
Q3 2013$663,000
+35.0%
65,6870.0%0.01%
+25.0%
Q2 2013$491,00065,6870.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders